Sun Pharma drug combo scores FDA approval in advanced castration-resistant prostate cancer
May 23, 2018Research and Development, Sales and Marketing Cancer, Churchill Pharmaceuticals, FDA, Sun Pharma, US, Yonsa, pharma, prostate cancer
Sun Pharma is celebrating with the announcement that its CYP17 inhibitor Yonsa (abiraterone acetate) has been awarded FDA approval in …
World heading towards 25% of total population being obese
May 23, 2018Research and Development WHO, biotech, drugs, obesity, pharma, pharmaceutical
The latest global research paints a bleak picture of future global public health, predicting that almost a quarter of the …
FDA reprimands suppliers of opioid substitute kratom products
May 23, 2018Research and Development, Sales and Marketing FDA, kratom, opioid crisis, opioids, pharma
The ongoing opioid epidemic in the US has seen the rise of the sale and use of kratom (mitragyna speciose), …
Takeda begins to shore up finances with $280m divestment
May 23, 2018Research and Development, Sales and Marketing Takeda, biotech, drugs, pharma, pharmaceutical
Much has already been written about Takeda and its massive financial stretch to pull in the Shire acquisition, in the …
India, Sweden and The Netherlands form HIV/AIDS research partnership
May 22, 2018Manufacturing and Production, Research and Development AIDS, HIV, India, Sweden, The Netherlands, pharma
A first-of-its-kind collaboration has been announced by the governments of India, Sweden and The Netherlands with the goal of advancing …
NHS Trust harnesses AI to speed up treatment
May 22, 2018Manufacturing and Production, Medical Communications AI, NHS, biotech, drugs, pharma, pharmaceutical
The Royal Liverpool and Broadgreen University Hospitals NHS Trust has teamed up with a provider of AI systems to introduce …
The cause of the most common form of childhood cancer found
May 22, 2018Manufacturing and Production, Research and Development biotech, drugs, leukaemia, pharma, pharmaceutical
Professor Mel Greaves, of The Institute of Cancer Research, has spent 30 years uncovering what is behind the mysterious rise …
ViiV’s two-drug regimen gets EU approval for HIV-1
May 22, 2018Manufacturing and Production, Sales and Marketing EMA, EU, Europe, HIV, Juluca, ViiV Healthcare, pharma
ViiV Healthcare has announced that its HIV therapy Juluca (dolutegravir/rilpivirine) has been awarded marketing authorisation in the EU from the …
Nabriva closes in on bringing new class of antibiotic to market
May 22, 2018Manufacturing and Production, Sales and Marketing Antibiotics, Nabriva Therapeutics, biotech, drugs, pharma, pharmaceutical
Nabriva Therapeutics, a biotech based in Dublin, Ireland, has announced positive Phase 3 data for its antibiotic, lefamulin, which could …
Gilead expands operations in Cork, Ireland
May 21, 2018Manufacturing and Production, Sales and Marketing Gilead, Ireland, biotech, drugs, pharma, pharmaceutical
Gilead has unveiled the expansion of its Cork manufacturing site, involved in the creation of its treatments for HIV and …
Clinical trials, Brexit and the question of ‘full alignment’
May 21, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit, clinical trials, feature, pharma
Gene Matthews, Partner at Leigh Day, reviews the tough decisions the UK has to make regarding its position in the …
EMA review confirms risks of Abbvie and Biogen’s Zinbryta outweigh benefits
May 21, 2018Research and Development, Sales and Marketing EMA, Europe, European Commission, PRAC, multiple sclerosis, pharma, zinbryta
The EMA has judged that the benefits offered by Zinbryta (daclizumab), Abbvie and Biogen’s humanised IgG1 monoclonal antibody for the …
Roche’s Hemlibra stakes claim to be haemophilia market leader
May 21, 2018Research and Development, Sales and Marketing Hemlibra, Roche, Shire, biotech, drugs, haemophilia, pharma, pharmaceutical
Hemlibra was widely expected to become the dominant therapeutic for treating haemophilia patients and its latest clinical trial results only …
FDA approves AZ’s Lokelma for hyperkalaemia
May 21, 2018Sales and Marketing AstraZeneca, FDA, Lokelma, hyperkalaemia, pharma
The FDA has revealed its decision to approve AstraZeneca’s oral potassium-removing agent Lokelma (sodium zirconium cyclosilicate) for the treatment of …
Investigation of kickbacks in Greece sputters to halt
May 21, 2018Sales and Marketing Greece, Novartis, biotech, drugs, pharma, pharmaceutical
Greek parliament has decided against investigating allegations of bribery, involving Novartis and numerous high-level former politicians. The case has dominated …
Top Ten most popular articles on Pharmafile.com this week
May 18, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, Novartis, Takeda, Trump, brexit, pharma, pharmafile, top ten
The year is flying by – it’s another Friday, and that means another Top Ten run-down.Perhaps the biggest story this …
Ebola threat intensifies in DR Congo
May 18, 2018Medical Communications Ebola, MSD, biotech, drugs, pharma, pharmaceutical
The Ebola outbreak in the Democratic Republic of Congo is becoming increasingly serious, after it was confirmed that there was …
Pfizer’s Lyrica achieves endpoint as adjunct in paediatric epilepsy
May 18, 2018Medical Communications, Research and Development FDA, Lyrica, Pfizer, epilepsy, pharma
Pfizer has revealed new Phase 3 data for its oral epilepsy therapy Lyrica (pregbalin) as an adjunctive treatment for partial …
Amgen/Novartis potential blockbuster migraine med gets FDA nod
May 18, 2018Medical Communications, Sales and Marketing Allergan, Amgen, Novartis, biotech, drugs, migraine, pharma, pharmaceutical
The first in a new class of migraine treatments has just received approval from the FDA; Amgen and Novartis’ Aimovig …
Study finds Herceptin use can be halved
May 17, 2018Medical Communications, Research and Development Herceptin, Roche, biosimilars, biotech, drugs, pharma, pharmaceutical
A team of researchers from the University of Cambridge and Warwick Clinical Trials have revealed that Roche’s Herceptin is just …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
